FUSION ANTIBODIES PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.45 GBX | +1.47% |
|
+1.47% | -18.82% |
| Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
| Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FUSION ANTIBODIES PLC | Other Biotechnology & Medical Research | +1.47% | +1.47% | -18.82% | -55.48% | -94.00% | 4.12M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- FAB Stock
- Charts Fusion Antibodies plc
- Comparison Chart
